The introduction of efficacious new hepatitis C virus (HCV) treatments galvanized the World
Health Organization to define ambitious targets for eliminating HCV as a public health threat …

AIM To determine hepatitis C virus (HCV) infection prevalence in each country of the Middle-
East and the overall prevalence of the region. METHODS In this systematic review, we …

While hepatitis B virus (HBV) screening relies on hepatitis B surface antigen to confirm HBV
infection since the early days of hepatitis B disease management, hepatitis C virus (HCV) …

Introduction: The diagnostic procedure for chronic hepatitis C infection (CHC) usually
combines anti‐HCV antibody (HCV‐Ab) and HCV‐RNA measurement. Quantifying HCV …

Objectives We sought to investigate the clinical usefulness of the level of plasma OPN,
compared to α-fetoprotein (AFP), as a biomarker for hepatocellular carcinoma (HCC) and to …

Background As direct acting antiviral (DAA) therapy is progressively rolled out for patients
with hepatitis C virus (HCV) infection, careful scrutiny of HCV epidemiology, diagnostic …

Introduction Detection of hepatitis C virus (HCV) RNA and the HCV core antigen assay (HCV-
Ag) are reliable techniques for the diagnosis of active and chronic HCV infection. Our aim …

Background: Hepatitis C virus (HCV) is a major cause of liver disease and a potential cause
of substantial morbidity and mortality. This study aims to provide a comprehensive evidence …

India contributes significantly to the global burden of HCV. While the nucleoside NS5B
inhibitor sofosbuvir became available in the Indian market in March 2015, the other directly …

Liver disease secondary to chronic hepatitis C virus (HCV) infection is an important cause of
morbidity and mortality in patients with end‐stage renal disease (ESRD) on renal …